DMD and Duchenne muscular dystrophy: Li et al. [45] also performed and demonstrated genetic correction of dystrophin in DMD patient-derived iPSCs using both the CRISPR/Cas9 and TALEN platforms, and subsequently performed a genome-wide analysis for off-target mutations.